Genomics

  1. No evidence that plasmablasts transdifferentiate into developing neutrophils in severe COVID‐19 disease

    1. José Alquicira‐Hernandez
    2. Joseph E Powell
    3. Tri Giang Phan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples

    1. Tiantian Liu
    2. Zhong Chen
    3. Wanqiu Chen
    4. Xin Chen
    5. Maryam Hosseini
    6. Zhaowei Yang
    7. Jing Li
    8. Diana Ho
    9. David Turay
    10. Ciprian Gheorghe
    11. Wendell Jones
    12. Charles Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations

    1. Jobin John Jacob
    2. Karthick Vasudevan
    3. Agila Kumari Pragasam
    4. Karthik Gunasekaran
    5. Balaji Veeraraghavan
    6. Ankur Mutreja

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity

    1. Nicholas S. Giroux
    2. Shengli Ding
    3. Micah T. McClain
    4. Thomas W. Burke
    5. Elizabeth Petzold
    6. Hong A. Chung
    7. Grecia R. Palomino
    8. Ergang Wang
    9. Rui Xi
    10. Shree Bose
    11. Tomer Rotstein
    12. Bradly P. Nicholson
    13. Tianyi Chen
    14. Ricardo Henao
    15. Gregory D. Sempowski
    16. Thomas N. Denny
    17. Emily R. Ko
    18. Geoffrey S. Ginsburg
    19. Bryan D. Kraft
    20. Ephraim L. Tsalik
    21. Christopher W. Woods
    22. Xiling Shen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV)

    1. Qiang Huang
    2. Andreas Herrmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Quality control of low-frequency variants in SARS-CoV-2 genomes

    1. Mikhail Rayko
    2. Aleksey Komissarov

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  7. From partial to whole genome imputation of SARS-CoV-2 for epidemiological surveillance

    1. Francisco M Ortuño
    2. Carlos Loucera
    3. Carlos S. Casimiro-Soriguer
    4. Jose A. Lepe
    5. Pedro Camacho Martinez
    6. Laura Merino Diaz
    7. Adolfo de Salazar
    8. Natalia Chueca
    9. Federico García
    10. Javier Perez-Florido
    11. Joaquin Dopazo

    Reviewed by GigaScience, ScreenIT

    3 evaluationsAppears in 2 listsLatest version Latest activity

  8. Rapid structure-function insights via hairpin-centric analysis of big RNA structure probing datasets

    1. Pierce Radecki
    2. Rahul Uppuluri
    3. Sharon Aviran

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Gene expression network analysis provides potential targets against SARS-CoV-2

    1. Ana I. Hernández Cordero
    2. Xuan Li
    3. Chen Xi Yang
    4. Stephen Milne
    5. Yohan Bossé
    6. Philippe Joubert
    7. Wim Timens
    8. Maarten van den Berge
    9. David Nickle
    10. Ke Hao
    11. Don D. Sin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. How did SARS-CoV-19 spread in India from Italy, Iran and China? Genetic surveillance of early cases and virus demography

    1. Mukesh Thakur
    2. Abhishek Singh
    3. Bheem Dutt Joshi
    4. Avijit Ghosh
    5. Sujeet Kumar Singh
    6. Neha Singh
    7. Lalit Kumar Sharma
    8. Kailash Chandra

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity
Previous Page 63 of 78 Next